Mylearn tablets are used to treat certain types of cancer, such as chronic leukemia. They contain busulfan, which destroys cancer cells by affecting DNA and preventing cell division. They are often used as part of preparing the patient for a bone marrow transplant, as they help reduce the number of malignant cells and prepare the body to receive new cells. They are taken orally in precisely defined doses. The patient requires continuous medical supervision because
Mylearn may cause a severe decrease in blood cells and complications in the liver and lungs. Body temperature and respiratory symptoms must also be monitored continuously. The drug should not be used during pregnancy or breastfeeding, and the doctor must be informed about all medications and supplements being taken to avoid interactions and serious complications.